Pfizer’s COVID-19 vaccine for XBB.1.5 subvariant approved in U.K. – National
Descrease article font size Increase article font size The U.K. drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets only the Omicron XBB.1.5 subvariant. The vaccine, which like their other COVID shots will also be sold under brand Comirnaty, has been approved for … Read more